Paul Danziger

Paul Danziger is a Texas-based attorney who has dedicated a significant portion of his legal career to representing individuals diagnosed with mesothelioma and other asbestos-related diseases. For patients and families navigating one of the most devastating diagnoses in oncology, Danziger has served as both a legal advocate and an accessible source of practical information about the rights of asbestos exposure victims. His work sits at the intersection of medicine, law, and patient support, a space that is critically underserved for the roughly 3,000 Americans diagnosed with mesothelioma each year, according to the National Cancer Institute (NCI).

Danziger's practice focuses on holding corporations accountable for knowingly exposing workers and consumers to asbestos, a carcinogenic mineral whose link to mesothelioma has been established in the medical literature since the 1960s. Asbestos litigation in the United States is among the longest-running mass tort in legal history, with tens of thousands of cases filed annually. According to the RAND Corporation's 2005 study on asbestos litigation, more than 730,000 people had filed asbestos-related claims against approximately 8,400 defendants as of the time of publication, a number that has continued to grow.

Beyond courtroom work, Danziger has contributed educational content aimed at helping patients understand their diagnoses, treatment options, and legal rights. This dual role, as both practitioner and educator, reflects a broader trend among mesothelioma attorneys who recognize that clients often arrive at their offices overwhelmed by medical information they don't yet understand. His contributions to resources like Mesothelioma-Lung-Cancer.org reflect that commitment to patient-centered advocacy.

While Paul Danziger is not a physician and does not provide medical treatment, his work directly intersects with the treatment landscape for mesothelioma patients in a practical and financially consequential way. Mesothelioma treatment, which may include surgery, chemotherapy, radiation therapy, and increasingly immunotherapy, is extraordinarily expensive. According to a 2020 analysis published in the Journal of Thoracic Oncology, the median cost of mesothelioma treatment in the United States exceeds $150,000 per patient, and many patients face costs well above that figure depending on their treatment protocol and duration of care.

Attorneys like Danziger help bridge the gap between a patient's diagnosis and their ability to access financial resources through legal compensation. Asbestos trust funds, established by bankrupt asbestos manufacturers, hold an estimated $30 billion in assets designated for victims, according to the RAND Institute for Civil Justice. Accessing those funds, however, requires legal expertise. Danziger's role in guiding clients through trust fund claims, personal injury lawsuits, and veterans' benefits claims means that his work can directly affect whether a patient can afford the treatments their oncologist recommends.

His patient advocacy work also involves helping families understand the timeline of legal action relative to medical urgency. Because mesothelioma carries a median survival of 12 to 21 months from diagnosis, according to the NCI, the window for pursuing legal claims while a patient is still alive to participate in their own case is often narrow. Danziger and attorneys in his field routinely work on expedited schedules to ensure clients receive compensation during their lifetimes rather than posthumously through wrongful death claims.

The prognosis for mesothelioma patients, independent of legal representation, remains poor. The five-year survival rate for all stages of pleural mesothelioma is approximately 12%, according to the NCI's PDQ treatment summary. Peritoneal mesothelioma patients who qualify for cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC) fare somewhat better, with some studies reporting five-year survival rates of 40 to 50% in carefully selected patients, as noted in a 2019 review in Annals of Surgical Oncology.

From a legal prognosis standpoint, patients who retain experienced mesothelioma attorneys early in their diagnosis tend to achieve better financial outcomes. A 2021 analysis by the Mesothelioma Applied Research Foundation found that patients with legal representation were significantly more likely to access asbestos trust fund compensation and to receive settlements or verdicts that covered both medical costs and non-economic damages such as pain and suffering. Danziger's focus on early engagement with clients reflects this reality. The legal process, even when expedited, takes time, and the sooner a claim is filed, the more options remain available.

Imagine receiving a mesothelioma diagnosis on a Tuesday and, by Friday, trying to understand not only what your oncologist is recommending but also whether you have legal rights, who might be responsible for your exposure, and how you'll pay for treatment that costs more per month than most people earn in a year. That's the situation Paul Danziger's clients typically face, and it's one that shapes every aspect of his practice.

For patients and families living with a mesothelioma diagnosis, the legal dimension of the disease is inseparable from the medical one. Financial stress is a documented contributor to worse health outcomes in cancer patients. A 2019 study in JAMA Oncology found that financial toxicity, defined as the material and psychological burden of cancer costs, was associated with higher mortality risk and lower quality of life across multiple cancer types. Attorneys who specialize in asbestos litigation, including Danziger, argue that securing compensation isn't just about justice; it's about giving patients the financial stability to focus on their health.

Danziger's educational contributions, including articles and guides aimed at newly diagnosed patients, address practical questions: What is mesothelioma? How does asbestos cause it? What are your legal options? How long does a claim take? These resources serve a population that is often older, frequently veterans (who account for approximately 30% of all mesothelioma diagnoses, according to the U.S. Department of Veterans Affairs), and sometimes unfamiliar with navigating complex legal and medical systems simultaneously.

Support organizations such as the Mesothelioma Applied Research Foundation and the American Cancer Society both recommend that mesothelioma patients consult with an experienced asbestos attorney as early as possible after diagnosis, specifically because statutes of limitations, which typically run one to three years from the date of diagnosis depending on the state, can foreclose legal options for patients who wait too long.